Introduction
Activation of monocytes results in the secretion of numerous cytokines, including 11-1 and tumour necrosis factor o (TNF-o), which play key roles in regulation of the immune system. 1'2 However, unregulated overproduction of these cytokines has been cited as a major factor in the development of septic shock, rheumatoid arthritis and inflammatory lesions. 1'2 Thus, the production of these cytokines must be tightly controlled by numerous mechanisms. Macrophage activation induces a rise in the rate of transcription for IL-1 and TNF-o mRNA and a concurrent increase in the stability 1 (10 #M) in an additive manner. Vinpocetine had no effect on rolipram's suppression of TNF-0. Zaprinast ficantly augmented secreted TNF-z production (p 0.004), the apparent increase in cell associated TNF-0 by zaprinast was not significant (p 0.2).
Similar to zaprinast's effects on IL-lfi secretion, the level of cell associated IL-lfi was significantly augmented by zaprinast (Fig. 4B) 29 Furthermore, TNF-was reported to stimulate eosinophil oxidant production and toxicity towards human endothelium. 3 Thus, it may also be suggested that the anti-TNF<z activities of PDE-IV inhibitors will contribute to their anti-asthma profiles. Further experiments will be needed to explore this possibility.
